CIJI SMITH: Open Payments
NPI 1609582097 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 76 payments from 15 companies in 2025. Trend: 2023 $255 · 2024 $1,483 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $469 |
| ABBVIE INC. | 19 | $354 |
| Novo Nordisk Inc | 16 | $299 |
| Lilly USA, LLC | 3 | $67 |
| Dexcom, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 2 | $56 |
| SHIELD THERAPEUTICS INC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Exact Sciences Corporation | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: AIRSUPRA, VRAYLAR, Ozempic, BREZTRI, QULIPTA, Wegovy, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across AZ — which companies pay providers there.
